ALTO-300 oral (PO) tablet

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
ALTO-300 in DepressionNCT05118750Alto NeurosciencePhase 2Completed2023-05-05Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.